Based on the findings from Ach, restoring ACh levels with the combined use of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors may constitute a successful therapy strategy for AD. The gene discussed is ACHE; the disease is Alzheimer disease.